Suchergebnisse - "Gerckens, Miriam"

PubPharm (7)

1

Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma : the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers

enthalten in: Journal of cancer research and clinical oncology | 2023

von Dorman, K. | Gerckens, M. | Kruger, S. | +15

2

Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood

enthalten in: Biomedicines | 2022

von Krueger, K. | Mayer, Z. | Kottmaier, M. | +4

3

High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood

enthalten in: Biomedicines | 2022

von Krueger, K. | Mayer, Z. | Gerckens, M. | +3

4

Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers

enthalten in: Journal of cancer research and clinical oncology | 2022

von Dorman, K. | Gerckens, M. | Kruger, S. | +15

5

Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers

enthalten in: Journal of cancer research and clinical oncology | 2022

von Dorman, K. | Gerckens, M. | Kruger, S. | +15

6

Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers

enthalten in: Journal of cancer research and clinical oncology | 2022

von Dorman, K. | Gerckens, M. | Kruger, S. | +15

7

Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers

enthalten in: ResearchSquare.com | 2022

von Dorman, K. | Gerckens, M. | Kruger, S. | +15

1
[1]